We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HROWM market cap is 954.83M. The company's latest EPS is USD -0.6854 and P/E is -36.62.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 34.27M | 36.36M | 34.59M | 48.94M | 49.26M |
| Operating Income | 1.74M | -4.88M | -6.93M | 1.53M | 1.32M |
| Net Income | -4.39M | -9.15M | -13.57M | -6.47M | -4.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 51.17M | 48.87M | 72.48M | 88.6M | 130.19M |
| Operating Income | -763k | 385k | 1.61M | -9.21M | 431k |
| Net Income | 168k | -3.36M | -18.01M | -14.09M | -24.41M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 286.07M | 312.16M | 295.54M | 306.63M | 351.54M |
| Total Liabilities | 210.66M | 241.75M | 235.33M | 248.45M | 293.92M |
| Total Equity | 75.4M | 70.41M | 60.21M | 58.18M | 57.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.09M | 57.47M | 98.33M | 157.38M | 312.16M |
| Total Liabilities | 31.67M | 30.65M | 87.4M | 130.14M | 241.75M |
| Total Equity | 27.42M | 26.83M | 10.93M | 27.24M | 70.41M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.86M | 3.84M | -4.63M | -7.37M | -4.42M |
| Investing | -152.35M | -152.55M | -110k | 4.99M | 4.4M |
| Financing | 126.55M | 126.53M | -809k | -736k | -1.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 950k | -1.1M | 5.08M | 1.71M | 3.84M |
| Investing | -1.83M | -981k | -18.69M | -1.74M | -152.55M |
| Financing | -1.01M | 1.43M | 51.47M | 54.14M | 126.53M |
| Market Cap | 954.83M |
| Price to Earnings Ratio | -36.62 |
| Price to Sales Ratio | 6.87 |
| Price to Cash Ratio | 12.07 |
| Price to Book Ratio | 12.7 |
| Dividend Yield | 11.07% |
| Shares Outstanding | 35.61M |
| Average Volume (1 week) | 2.67k |
| Average Volume (1 Month) | 3.58k |
| 52 Week Change | 5.22% |
| 52 Week High | 27.72 |
| 52 Week Low | 25.29 |
| Spread (Intraday) | 0.85 (3.08%) |
| Company Name | Harrow Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.harrow.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
